ResearcherFudan UniversityActive in the last 2 years

Caili Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5032216058. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer. Co-author DOI 10.1016/j.biopha.2024.117550 ↗
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer. Co-author DOI 10.1186/s12951-023-02183-9 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xuyao Zhang · 2 shared papers, 2023–2024 · strength 0.37
- Paper Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer. DOI 10.1016/j.biopha.2024.117550 ↗
- Paper TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer. DOI 10.1186/s12951-023-02183-9 ↗
Jing Huang · 1 shared paper, 2023 · strength 0.16
- Paper TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer. DOI 10.1186/s12951-023-02183-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.